Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Committee reviews bill to classify tianeptine as Schedule I amid safety and criminalization debate

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senator Sarah Hansen presented House Bill 21 to the Senate Health and Social Services Committee, asking the panel to classify tianeptine as a Schedule I controlled substance and ban its sale in places such as gas stations and vape shops.

Senator Sarah Hansen presented House Bill 21 to the Senate Health and Social Services Committee, asking the panel to classify tianeptine as a Schedule I controlled substance and ban its sale in places such as gas stations and vape shops.

Supporters told the committee they view the drug as a growing public-health threat: the Department of Justice and the Delaware State Police said early action could prevent wider availability, and the Medical Society of Delaware urged the ban citing dependence, withdrawal and documented severe side effects.

The bill’s sponsor, Representative Williams, alerted lawmakers after receiving reports from a school in her district that referenced information from the Children’s Hospital of Philadelphia and the Poison Control Center. Senator Hansen summarized those reports during the presentation and said that Poison Control had received about 15 adverse-exposure reports tied to tianeptine in the Pennsylvania and Delaware Avenue area.

Christy, a Department of Justice witness, told the committee that…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans